1. Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, et al.
Epidemiology, patterns of care, and mortality for patients with acute
respiratory distress syndrome in intensive care units in 50 countries. JAMA.
2016;315:788–800.
2. Charlson ES, Bittinger K, Haas AR, Fitzgerald AS, Frank I, Yadav A, et al.
Topographical continuity of bacterial populations in the healthy human
respiratory tract. Am J Respir Crit Care Med. 2011;184:957–63.
Kyo et al. Respiratory Research
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
(2019) 20:246
Garzoni C, Brugger SD, Qi W, Wasmer S, Cusini A, Dumont P, et al. Microbial
communities in the respiratory tract of patients with interstitial lung disease.
Thorax. 2013;68:1150–6.
Bousbia S, Papazian L, Saux P, Forel JM, Auffray JP, Martin C, et al. Repertoire
of intensive care unit pneumonia microbiota. PLoS One. 2012;7:e32486.
Dickson RP, Erb-Downward JR, Freeman CM, McCloskey L, Falkowski NR,
Huffnagle GB, et al. Bacterial topography of the healthy human lower
respiratory tract. MBio. 2017;8. https://doi.org/10.1128/mBio.02287-16.
Han MK, Zhou Y, Murray S, Tayob N, Noth I, Lama VN, et al. Lung
microbiome and disease progression in idiopathic pulmonary fibrosis: an
analysis of the COMET study. Lancet Respir Med. 2014;2:548–56.
Molyneaux PL, Cox MJ, Willis-Owen SA, Mallia P, Russell KE, Russell AM, et al.
The role of bacteria in the pathogenesis and progression of idiopathic
pulmonary fibrosis. Am J Respir Crit Care Med. 2014;190:906–13.
O'Dwyer DN, Ashley SL, Gurczynski SJ, Xia M, Wilke C, Falkowski NR, et al.
Lung microbiota contribute to pulmonary inflammation and disease
progression in pulmonary fibrosis. Am J Respir Crit Care Med. 2019;199:
1127–38.
Leitao Filho FS, Alotaibi NM, Ngan D, Tam S, Yang J, Hollander Z, et al.
Sputum microbiome is associated with 1-year mortality following COPD
hospitalizations. Am J Respir Crit Care Med. 2019;199:1205–13.
Prevaes SM, de Winter-de Groot KM, Janssens HM, de Steenhuijsen Piters
WA, Tramper-Stranders GA, Wyllie AL, et al. Development of the
nasopharyngeal microbiota in infants with cystic fibrosis. Am J Respir Crit
Care Med. 2016;193:504–15.
Dickson RP, Singer BH, Newstead MW, Falkowski NR, Erb-Downward JR,
Standiford TJ, et al. Enrichment of the lung microbiome with gut
bacteria in sepsis and the acute respiratory distress syndrome. Nat
Microbiol. 2016;1:16113.
Panzer AR, Lynch SV, Langelier C, Christie JD, McCauley K, Nelson M, et al.
Lung microbiota is related to smoking status and to development of acute
respiratory distress syndrome in critically ill trauma patients. Am J Respir Crit
Care Med. 2018;197:621–31.
Segal LN, Alekseyenko AV, Clemente JC, Kulkarni R, Wu B, Gao Z, et al.
Enrichment of lung microbiome with supraglottic taxa is associated with
increased pulmonary inflammation. Microbiome. 2013;1:19.
Segal LN, Clemente JC, Tsay JC, Koralov SB, Keller BC, Wu BG, et al.
Enrichment of the lung microbiome with oral taxa is associated with lung
inflammation of a Th17 phenotype. Nat Microbiol. 2016;1:16031.
Bernasconi E, Pattaroni C, Koutsokera A, Pison C, Kessler R, Benden C,
et al. Airway microbiota determines innate cell inflammatory or tissue
remodeling profiles in lung transplantation. Am J Respir Crit Care Med.
2016;194:1252–63.
Force ADT, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell
E, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA.
2012;307:2526–33.
Akiyama K, Nishioka K, Khan KN, Tanaka Y, Mori T, Nakaya T, et al. Molecular
detection of microbial colonization in cervical mucus of women with and
without endometriosis. Am J Reprod Immunol. 2019;82:e13147.
Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello
EK, et al. QIIME allows analysis of high-throughput community sequencing
data. Nat Methods. 2010;7:335–6.
Shen W, Le S, Li Y, Hu F. SeqKit: a cross-platform and ultrafast toolkit for
FASTA/Q file manipulation. PLoS One. 2016;11:e0163962.
Goleva E, Jackson LP, Harris JK, Robertson CE, Sutherland ER, Hall CF, et al.
The effects of airway microbiome on corticosteroid responsiveness in
asthma. Am J Respir Crit Care Med. 2013;188:1193–201.
Bassis CM, Erb-Downward JR, Dickson RP, Freeman CM, Schmidt TM, Young
VB, et al. Analysis of the upper respiratory tract microbiotas as the source of
the lung and gastric microbiotas in healthy individuals. MBio. 2015;6:e00037.
Nseir S, Zerimech F, Jaillette E, Artru F, Balduyck M. Microaspiration in
intubated critically ill patients: diagnosis and prevention. Infect Disord Drug
Targets. 2011;11:413–23.
Poroyko V, Meng F, Meliton A, Afonyushkin T, Ulanov A, Semenyuk E, et al.
Alterations of lung microbiota in a mouse model of LPS-induced lung
injury. Am J Physiol Lung Cell Mol Physiol. 2015;309:L76–83.
Huffnagle GB, Dickson RP, Lukacs NW. The respiratory tract microbiome and
lung inflammation: a two-way street. Mucosal Immunol. 2017;10:299–306.
Bingula R, Filaire M, Radosevic-Robin N, Bey M, Berthon JY, BernalierDonadille A, et al. Desired turbulence? Gut-lung Axis, immunity, and lung
cancer. J Oncol. 2017;2017:5035371.
Page 9 of 9
26. Stanley D, Moore RJ, Wong CHY. An insight into intestinal mucosal
microbiota disruption after stroke. Sci Rep. 2018;8:568.
27. Kelly BJ, Imai I, Bittinger K, Laughlin A, Fuchs BD, Bushman FD, et al.
Composition and dynamics of the respiratory tract microbiome in intubated
patients. Microbiome. 2016;4:7.
28. O'Dwyer DN, Dickson RP, Moore BB. The lung microbiome, immunity, and
the pathogenesis of chronic lung disease. J Immunol. 2016;196:4839–47.
29. Mouraux S, Bernasconi E, Pattaroni C, Koutsokera A, Aubert JD, Claustre J,
et al. Airway microbiota signals anabolic and catabolic remodeling in the
transplanted lung. J Allergy Clin Immunol. 2018;141:718–29 e717.
30. Knippenberg S, Ueberberg B, Maus R, Bohling J, Ding N, Tort Tarres M, et al.
Streptococcus pneumoniae triggers progression of pulmonary fibrosis
through pneumolysin. Thorax. 2015;70:636–46.
31. Stock CJ, Sato H, Fonseca C, Banya WA, Molyneaux PL, Adamali H, et al.
Mucin 5B promoter polymorphism is associated with idiopathic pulmonary
fibrosis but not with development of lung fibrosis in systemic sclerosis or
sarcoidosis. Thorax. 2013;68:436–41.
32. Marri PR, Stern DA, Wright AL, Billheimer D, Martinez FD. Asthma-associated
differences in microbial composition of induced sputum. J Allergy Clin
Immunol. 2013;131:346–52 e341–3.
33. Teo SM, Mok D, Pham K, Kusel M, Serralha M, Troy N, et al. The infant
nasopharyngeal microbiome impacts severity of lower respiratory infection
and risk of asthma development. Cell Host Microbe. 2015;17:704–15.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
...
論文の公開元へ
